Unmanaged Type 2 Diabetes is Expensive For Employers

Unmanaged Type 2 Diabetes is Expensive For Employers

Posted Dec 1, 2017

Educating employees about their medications and modifying habits will result in increased adherence to prescribed maintenance medications, as well as illuminating other blind spots.  PharmMD has a strategic plan to save lives and create healthier individuals. Read our case study.

Rising Diabetes Rates Are Costly for Employers

Source: SHRM published on November 14, 2017

About PharmMD: For Health Plans or risk-bearing entities that want to improve member and employee health measurably, PharmMD is the proven choice for pharmacy quality solutions. Founded by healthcare and pharmacy innovators, PharmMD’s outcomes-driven reporting, priority on personal touch, and scalable network are backed by performance-based pricing that guarantees fast results. Areas of expertise include: HEDIS, Part D Stars, Medication Therapy Management, Medication Risk Management.